nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—stomach cancer	0.466	0.827	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—stomach cancer	0.0974	0.173	CbGbCtD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—IDH3B—stomach cancer	0.00182	0.0938	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—SUCLG1—stomach cancer	0.00182	0.0938	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism—PDHA1—stomach cancer	0.00161	0.0828	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—PPIA—stomach cancer	0.00115	0.0593	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—PDHA1—stomach cancer	0.000973	0.0501	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—IDH3B—stomach cancer	0.000707	0.0364	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SUCLG1—stomach cancer	0.000707	0.0364	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFS1—stomach cancer	0.000657	0.0338	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFV1—stomach cancer	0.000657	0.0338	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—ITGA5—stomach cancer	0.000536	0.0276	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—CAV1—stomach cancer	0.000533	0.0274	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFA2—stomach cancer	0.000498	0.0256	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—THBD—stomach cancer	0.000414	0.0213	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PPIA—stomach cancer	0.000383	0.0197	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—PDHA1—stomach cancer	0.000377	0.0194	CbGpPWpGaD
Foscarnet—Chest pain—Capecitabine—stomach cancer	0.000311	0.000744	CcSEcCtD
Foscarnet—Myalgia—Capecitabine—stomach cancer	0.000311	0.000744	CcSEcCtD
Foscarnet—Haematuria—Epirubicin—stomach cancer	0.00031	0.000743	CcSEcCtD
Foscarnet—Confusional state—Docetaxel—stomach cancer	0.00031	0.000743	CcSEcCtD
Foscarnet—Pharyngitis—Methotrexate—stomach cancer	0.00031	0.000742	CcSEcCtD
Foscarnet—Anxiety—Capecitabine—stomach cancer	0.00031	0.000742	CcSEcCtD
Foscarnet—Oedema—Docetaxel—stomach cancer	0.000308	0.000737	CcSEcCtD
Foscarnet—Discomfort—Capecitabine—stomach cancer	0.000307	0.000735	CcSEcCtD
Foscarnet—Urethral disorder—Methotrexate—stomach cancer	0.000306	0.000733	CcSEcCtD
Foscarnet—Infection—Docetaxel—stomach cancer	0.000306	0.000732	CcSEcCtD
Foscarnet—Weight decreased—Doxorubicin—stomach cancer	0.000305	0.000732	CcSEcCtD
Foscarnet—Sinusitis—Epirubicin—stomach cancer	0.000305	0.000731	CcSEcCtD
Foscarnet—Diarrhoea—Irinotecan—stomach cancer	0.000304	0.000729	CcSEcCtD
Foscarnet—Dry mouth—Capecitabine—stomach cancer	0.000304	0.000728	CcSEcCtD
Foscarnet—Agranulocytosis—Epirubicin—stomach cancer	0.000304	0.000727	CcSEcCtD
Foscarnet—Pruritus—Fluorouracil—stomach cancer	0.000302	0.000722	CcSEcCtD
Foscarnet—Thrombocytopenia—Docetaxel—stomach cancer	0.000301	0.000722	CcSEcCtD
Foscarnet—Confusional state—Capecitabine—stomach cancer	0.0003	0.000719	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000298	0.000715	CcSEcCtD
Foscarnet—Oedema—Capecitabine—stomach cancer	0.000298	0.000713	CcSEcCtD
Foscarnet—Renal failure—Doxorubicin—stomach cancer	0.000296	0.000709	CcSEcCtD
Foscarnet—Infection—Capecitabine—stomach cancer	0.000296	0.000709	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—stomach cancer	0.000295	0.000707	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000295	0.000707	CcSEcCtD
Foscarnet—Dizziness—Irinotecan—stomach cancer	0.000294	0.000705	CcSEcCtD
Foscarnet—Anorexia—Docetaxel—stomach cancer	0.000293	0.000702	CcSEcCtD
Foscarnet—Rhinitis—Epirubicin—stomach cancer	0.000293	0.000701	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—stomach cancer	0.000293	0.000701	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—stomach cancer	0.000293	0.000701	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—stomach cancer	0.000292	0.000699	CcSEcCtD
Foscarnet—Diarrhoea—Fluorouracil—stomach cancer	0.000292	0.000699	CcSEcCtD
Foscarnet—Thrombocytopenia—Capecitabine—stomach cancer	0.000292	0.000699	CcSEcCtD
Foscarnet—Hypoaesthesia—Epirubicin—stomach cancer	0.000291	0.000696	CcSEcCtD
Foscarnet—Pharyngitis—Epirubicin—stomach cancer	0.00029	0.000694	CcSEcCtD
Foscarnet—Hyperhidrosis—Capecitabine—stomach cancer	0.000288	0.00069	CcSEcCtD
Foscarnet—Hypotension—Docetaxel—stomach cancer	0.000287	0.000689	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—stomach cancer	0.000287	0.000688	CcSEcCtD
Foscarnet—Urethral disorder—Epirubicin—stomach cancer	0.000286	0.000686	CcSEcCtD
Foscarnet—Anorexia—Capecitabine—stomach cancer	0.000284	0.00068	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—CD44—stomach cancer	0.000284	0.0146	CbGpPWpGaD
Foscarnet—Vomiting—Irinotecan—stomach cancer	0.000283	0.000678	CcSEcCtD
Foscarnet—Sinusitis—Doxorubicin—stomach cancer	0.000282	0.000677	CcSEcCtD
Foscarnet—Dizziness—Fluorouracil—stomach cancer	0.000282	0.000675	CcSEcCtD
Foscarnet—Agranulocytosis—Doxorubicin—stomach cancer	0.000281	0.000673	CcSEcCtD
Foscarnet—Rash—Irinotecan—stomach cancer	0.000281	0.000672	CcSEcCtD
Foscarnet—Dermatitis—Irinotecan—stomach cancer	0.00028	0.000672	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00028	0.000671	CcSEcCtD
Foscarnet—Chills—Methotrexate—stomach cancer	0.00028	0.000671	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000279	0.0144	CbGpPWpGaD
Foscarnet—Headache—Irinotecan—stomach cancer	0.000279	0.000668	CcSEcCtD
Foscarnet—Hypotension—Capecitabine—stomach cancer	0.000278	0.000667	CcSEcCtD
Foscarnet—Insomnia—Docetaxel—stomach cancer	0.000278	0.000667	CcSEcCtD
Foscarnet—Paraesthesia—Docetaxel—stomach cancer	0.000276	0.000662	CcSEcCtD
Foscarnet—Erythema multiforme—Epirubicin—stomach cancer	0.000276	0.000661	CcSEcCtD
Foscarnet—Dyspnoea—Docetaxel—stomach cancer	0.000274	0.000657	CcSEcCtD
Foscarnet—Somnolence—Docetaxel—stomach cancer	0.000273	0.000655	CcSEcCtD
Foscarnet—Eye disorder—Epirubicin—stomach cancer	0.000273	0.000654	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000271	0.00065	CcSEcCtD
Foscarnet—Flushing—Epirubicin—stomach cancer	0.000271	0.000649	CcSEcCtD
Foscarnet—Vomiting—Fluorouracil—stomach cancer	0.000271	0.000649	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—stomach cancer	0.000271	0.000649	CcSEcCtD
Foscarnet—Dyspepsia—Docetaxel—stomach cancer	0.000271	0.000649	CcSEcCtD
Foscarnet—Insomnia—Capecitabine—stomach cancer	0.000269	0.000645	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—stomach cancer	0.000269	0.000644	CcSEcCtD
Foscarnet—Rash—Fluorouracil—stomach cancer	0.000269	0.000644	CcSEcCtD
Foscarnet—Dermatitis—Fluorouracil—stomach cancer	0.000269	0.000643	CcSEcCtD
Foscarnet—Pharyngitis—Doxorubicin—stomach cancer	0.000268	0.000642	CcSEcCtD
Foscarnet—Paraesthesia—Capecitabine—stomach cancer	0.000267	0.000641	CcSEcCtD
Foscarnet—Decreased appetite—Docetaxel—stomach cancer	0.000267	0.000641	CcSEcCtD
Foscarnet—Headache—Fluorouracil—stomach cancer	0.000267	0.00064	CcSEcCtD
Foscarnet—Dyspnoea—Capecitabine—stomach cancer	0.000266	0.000636	CcSEcCtD
Foscarnet—Fatigue—Docetaxel—stomach cancer	0.000265	0.000635	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—stomach cancer	0.000265	0.000635	CcSEcCtD
Foscarnet—Nausea—Irinotecan—stomach cancer	0.000264	0.000633	CcSEcCtD
Foscarnet—Constipation—Docetaxel—stomach cancer	0.000263	0.00063	CcSEcCtD
Foscarnet—Pain—Docetaxel—stomach cancer	0.000263	0.00063	CcSEcCtD
Foscarnet—Back pain—Methotrexate—stomach cancer	0.000263	0.00063	CcSEcCtD
Foscarnet—Dyspepsia—Capecitabine—stomach cancer	0.000262	0.000628	CcSEcCtD
Foscarnet—Chills—Epirubicin—stomach cancer	0.000262	0.000628	CcSEcCtD
Foscarnet—Decreased appetite—Capecitabine—stomach cancer	0.000259	0.00062	CcSEcCtD
Foscarnet—Fatigue—Capecitabine—stomach cancer	0.000257	0.000615	CcSEcCtD
Foscarnet—Erythema multiforme—Doxorubicin—stomach cancer	0.000256	0.000612	CcSEcCtD
Foscarnet—Pain—Capecitabine—stomach cancer	0.000255	0.00061	CcSEcCtD
Foscarnet—Constipation—Capecitabine—stomach cancer	0.000255	0.00061	CcSEcCtD
Foscarnet—Feeling abnormal—Docetaxel—stomach cancer	0.000254	0.000607	CcSEcCtD
Foscarnet—Nausea—Fluorouracil—stomach cancer	0.000253	0.000606	CcSEcCtD
Foscarnet—Eye disorder—Doxorubicin—stomach cancer	0.000253	0.000605	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—stomach cancer	0.000252	0.000604	CcSEcCtD
Foscarnet—Gastrointestinal pain—Docetaxel—stomach cancer	0.000252	0.000603	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—stomach cancer	0.000251	0.000602	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—stomach cancer	0.000251	0.000601	CcSEcCtD
Foscarnet—Flatulence—Epirubicin—stomach cancer	0.000251	0.0006	CcSEcCtD
Foscarnet—Tension—Epirubicin—stomach cancer	0.000249	0.000598	CcSEcCtD
Foscarnet—Nervousness—Epirubicin—stomach cancer	0.000247	0.000592	CcSEcCtD
Foscarnet—Back pain—Epirubicin—stomach cancer	0.000246	0.000589	CcSEcCtD
Foscarnet—Feeling abnormal—Capecitabine—stomach cancer	0.000245	0.000588	CcSEcCtD
Foscarnet—Malaise—Methotrexate—stomach cancer	0.000245	0.000587	CcSEcCtD
Foscarnet—Muscle spasms—Epirubicin—stomach cancer	0.000244	0.000586	CcSEcCtD
Foscarnet—Gastrointestinal pain—Capecitabine—stomach cancer	0.000244	0.000583	CcSEcCtD
Foscarnet—Abdominal pain—Docetaxel—stomach cancer	0.000243	0.000583	CcSEcCtD
Foscarnet—Body temperature increased—Docetaxel—stomach cancer	0.000243	0.000583	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—stomach cancer	0.000243	0.000583	CcSEcCtD
Foscarnet—Chills—Doxorubicin—stomach cancer	0.000242	0.000581	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000239	0.0123	CbGpPWpGaD
Foscarnet—Cough—Methotrexate—stomach cancer	0.000237	0.000568	CcSEcCtD
Foscarnet—Ill-defined disorder—Epirubicin—stomach cancer	0.000236	0.000565	CcSEcCtD
Foscarnet—Body temperature increased—Capecitabine—stomach cancer	0.000235	0.000564	CcSEcCtD
Foscarnet—Abdominal pain—Capecitabine—stomach cancer	0.000235	0.000564	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—stomach cancer	0.000235	0.000564	CcSEcCtD
Foscarnet—Anaemia—Epirubicin—stomach cancer	0.000235	0.000563	CcSEcCtD
Foscarnet—Agitation—Epirubicin—stomach cancer	0.000234	0.00056	CcSEcCtD
Foscarnet—Flatulence—Doxorubicin—stomach cancer	0.000232	0.000555	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—stomach cancer	0.000231	0.000554	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—stomach cancer	0.000231	0.000554	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—stomach cancer	0.000231	0.000554	CcSEcCtD
Foscarnet—Tension—Doxorubicin—stomach cancer	0.000231	0.000553	CcSEcCtD
Foscarnet—Malaise—Epirubicin—stomach cancer	0.000229	0.000549	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—stomach cancer	0.000229	0.000547	CcSEcCtD
Foscarnet—Nervousness—Doxorubicin—stomach cancer	0.000228	0.000547	CcSEcCtD
Foscarnet—Leukopenia—Epirubicin—stomach cancer	0.000228	0.000545	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—stomach cancer	0.000228	0.000545	CcSEcCtD
Foscarnet—Muscle spasms—Doxorubicin—stomach cancer	0.000226	0.000542	CcSEcCtD
Foscarnet—Palpitations—Epirubicin—stomach cancer	0.000225	0.000538	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—stomach cancer	0.000224	0.000536	CcSEcCtD
Foscarnet—Cough—Epirubicin—stomach cancer	0.000222	0.000531	CcSEcCtD
Foscarnet—Asthenia—Docetaxel—stomach cancer	0.000221	0.000529	CcSEcCtD
Foscarnet—Convulsion—Epirubicin—stomach cancer	0.00022	0.000528	CcSEcCtD
Foscarnet—Infection—Methotrexate—stomach cancer	0.00022	0.000528	CcSEcCtD
Foscarnet—Hypertension—Epirubicin—stomach cancer	0.00022	0.000526	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—stomach cancer	0.000218	0.000523	CcSEcCtD
Foscarnet—Pruritus—Docetaxel—stomach cancer	0.000218	0.000521	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—stomach cancer	0.000217	0.000521	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—stomach cancer	0.000217	0.00052	CcSEcCtD
Foscarnet—Arthralgia—Epirubicin—stomach cancer	0.000216	0.000518	CcSEcCtD
Foscarnet—Chest pain—Epirubicin—stomach cancer	0.000216	0.000518	CcSEcCtD
Foscarnet—Myalgia—Epirubicin—stomach cancer	0.000216	0.000518	CcSEcCtD
Foscarnet—Agitation—Doxorubicin—stomach cancer	0.000216	0.000518	CcSEcCtD
Foscarnet—Anxiety—Epirubicin—stomach cancer	0.000216	0.000517	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—stomach cancer	0.000214	0.000513	CcSEcCtD
Foscarnet—Discomfort—Epirubicin—stomach cancer	0.000214	0.000512	CcSEcCtD
Foscarnet—Asthenia—Capecitabine—stomach cancer	0.000214	0.000512	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—FYN—stomach cancer	0.000213	0.0109	CbGpPWpGaD
Foscarnet—Malaise—Doxorubicin—stomach cancer	0.000212	0.000508	CcSEcCtD
Foscarnet—Dry mouth—Epirubicin—stomach cancer	0.000212	0.000507	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—stomach cancer	0.000211	0.000506	CcSEcCtD
Foscarnet—Pruritus—Capecitabine—stomach cancer	0.000211	0.000505	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—stomach cancer	0.000211	0.000504	CcSEcCtD
Foscarnet—Diarrhoea—Docetaxel—stomach cancer	0.00021	0.000504	CcSEcCtD
Foscarnet—Confusional state—Epirubicin—stomach cancer	0.000209	0.000501	CcSEcCtD
Foscarnet—Palpitations—Doxorubicin—stomach cancer	0.000208	0.000498	CcSEcCtD
Foscarnet—Oedema—Epirubicin—stomach cancer	0.000208	0.000497	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—stomach cancer	0.000207	0.000496	CcSEcCtD
Foscarnet—Infection—Epirubicin—stomach cancer	0.000206	0.000494	CcSEcCtD
Foscarnet—Cough—Doxorubicin—stomach cancer	0.000205	0.000492	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—stomach cancer	0.000204	0.000488	CcSEcCtD
Foscarnet—Diarrhoea—Capecitabine—stomach cancer	0.000204	0.000488	CcSEcCtD
Foscarnet—Dizziness—Docetaxel—stomach cancer	0.000203	0.000487	CcSEcCtD
Foscarnet—Thrombocytopenia—Epirubicin—stomach cancer	0.000203	0.000487	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—stomach cancer	0.000203	0.000487	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000202	0.000484	CcSEcCtD
Foscarnet—Hyperhidrosis—Epirubicin—stomach cancer	0.000201	0.000481	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—stomach cancer	0.000201	0.00048	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—stomach cancer	0.0002	0.00048	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—stomach cancer	0.0002	0.00048	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—stomach cancer	0.0002	0.00048	CcSEcCtD
Foscarnet—Anxiety—Doxorubicin—stomach cancer	0.0002	0.000478	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—stomach cancer	0.000199	0.000477	CcSEcCtD
Foscarnet—Discomfort—Doxorubicin—stomach cancer	0.000198	0.000474	CcSEcCtD
Foscarnet—Anorexia—Epirubicin—stomach cancer	0.000198	0.000474	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—stomach cancer	0.000198	0.000474	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—stomach cancer	0.000197	0.000472	CcSEcCtD
Foscarnet—Dizziness—Capecitabine—stomach cancer	0.000197	0.000472	CcSEcCtD
Foscarnet—Dry mouth—Doxorubicin—stomach cancer	0.000196	0.000469	CcSEcCtD
Foscarnet—Vomiting—Docetaxel—stomach cancer	0.000196	0.000469	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—stomach cancer	0.000195	0.000468	CcSEcCtD
Foscarnet—Rash—Docetaxel—stomach cancer	0.000194	0.000465	CcSEcCtD
Foscarnet—Hypotension—Epirubicin—stomach cancer	0.000194	0.000464	CcSEcCtD
Foscarnet—Dermatitis—Docetaxel—stomach cancer	0.000194	0.000464	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—stomach cancer	0.000194	0.000464	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—stomach cancer	0.000193	0.000462	CcSEcCtD
Foscarnet—Headache—Docetaxel—stomach cancer	0.000193	0.000462	CcSEcCtD
Foscarnet—Oedema—Doxorubicin—stomach cancer	0.000192	0.00046	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—stomach cancer	0.000191	0.000458	CcSEcCtD
Foscarnet—Infection—Doxorubicin—stomach cancer	0.000191	0.000457	CcSEcCtD
Foscarnet—Pain—Methotrexate—stomach cancer	0.00019	0.000454	CcSEcCtD
Foscarnet—Vomiting—Capecitabine—stomach cancer	0.000189	0.000454	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000189	0.000453	CcSEcCtD
Foscarnet—Thrombocytopenia—Doxorubicin—stomach cancer	0.000188	0.00045	CcSEcCtD
Foscarnet—Rash—Capecitabine—stomach cancer	0.000188	0.00045	CcSEcCtD
Foscarnet—Insomnia—Epirubicin—stomach cancer	0.000188	0.00045	CcSEcCtD
Foscarnet—Dermatitis—Capecitabine—stomach cancer	0.000188	0.000449	CcSEcCtD
Foscarnet—Headache—Capecitabine—stomach cancer	0.000187	0.000447	CcSEcCtD
Foscarnet—Paraesthesia—Epirubicin—stomach cancer	0.000186	0.000446	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—stomach cancer	0.000186	0.000445	CcSEcCtD
Foscarnet—Dyspnoea—Epirubicin—stomach cancer	0.000185	0.000443	CcSEcCtD
Foscarnet—Somnolence—Epirubicin—stomach cancer	0.000184	0.000442	CcSEcCtD
Foscarnet—Anorexia—Doxorubicin—stomach cancer	0.000183	0.000438	CcSEcCtD
Foscarnet—Nausea—Docetaxel—stomach cancer	0.000183	0.000438	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—stomach cancer	0.000183	0.000438	CcSEcCtD
Foscarnet—Dyspepsia—Epirubicin—stomach cancer	0.000183	0.000438	CcSEcCtD
Foscarnet—Gastrointestinal pain—Methotrexate—stomach cancer	0.000181	0.000434	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000181	0.00933	CbGpPWpGaD
Foscarnet—Decreased appetite—Epirubicin—stomach cancer	0.00018	0.000432	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—stomach cancer	0.000179	0.00043	CcSEcCtD
Foscarnet—Fatigue—Epirubicin—stomach cancer	0.000179	0.000429	CcSEcCtD
Foscarnet—Constipation—Epirubicin—stomach cancer	0.000177	0.000425	CcSEcCtD
Foscarnet—Pain—Epirubicin—stomach cancer	0.000177	0.000425	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—CAV1—stomach cancer	0.000177	0.00913	CbGpPWpGaD
Foscarnet—Nausea—Capecitabine—stomach cancer	0.000177	0.000424	CcSEcCtD
Foscarnet—Abdominal pain—Methotrexate—stomach cancer	0.000175	0.00042	CcSEcCtD
Foscarnet—Body temperature increased—Methotrexate—stomach cancer	0.000175	0.00042	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000175	0.000419	CcSEcCtD
Foscarnet—Insomnia—Doxorubicin—stomach cancer	0.000174	0.000416	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—stomach cancer	0.000172	0.000413	CcSEcCtD
Foscarnet—Dyspnoea—Doxorubicin—stomach cancer	0.000171	0.00041	CcSEcCtD
Foscarnet—Feeling abnormal—Epirubicin—stomach cancer	0.000171	0.00041	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—stomach cancer	0.000171	0.000409	CcSEcCtD
Foscarnet—Gastrointestinal pain—Epirubicin—stomach cancer	0.00017	0.000406	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—SERPINB2—stomach cancer	0.000169	0.00872	CbGpPWpGaD
Foscarnet—Dyspepsia—Doxorubicin—stomach cancer	0.000169	0.000405	CcSEcCtD
Foscarnet—Decreased appetite—Doxorubicin—stomach cancer	0.000167	0.0004	CcSEcCtD
Foscarnet—Fatigue—Doxorubicin—stomach cancer	0.000166	0.000397	CcSEcCtD
Foscarnet—Pain—Doxorubicin—stomach cancer	0.000164	0.000393	CcSEcCtD
Foscarnet—Constipation—Doxorubicin—stomach cancer	0.000164	0.000393	CcSEcCtD
Foscarnet—Body temperature increased—Epirubicin—stomach cancer	0.000164	0.000393	CcSEcCtD
Foscarnet—Abdominal pain—Epirubicin—stomach cancer	0.000164	0.000393	CcSEcCtD
Foscarnet—Asthenia—Methotrexate—stomach cancer	0.000159	0.000381	CcSEcCtD
Foscarnet—Feeling abnormal—Doxorubicin—stomach cancer	0.000158	0.000379	CcSEcCtD
Foscarnet—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000157	0.000376	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—stomach cancer	0.000157	0.000376	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000155	0.00799	CbGpPWpGaD
Foscarnet—Abdominal pain—Doxorubicin—stomach cancer	0.000152	0.000364	CcSEcCtD
Foscarnet—Body temperature increased—Doxorubicin—stomach cancer	0.000152	0.000364	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—stomach cancer	0.000152	0.000363	CcSEcCtD
Foscarnet—Asthenia—Epirubicin—stomach cancer	0.000149	0.000357	CcSEcCtD
Foscarnet—Pruritus—Epirubicin—stomach cancer	0.000147	0.000352	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—stomach cancer	0.000147	0.000351	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ITGA5—stomach cancer	0.000145	0.00748	CbGpPWpGaD
Foscarnet—Diarrhoea—Epirubicin—stomach cancer	0.000142	0.00034	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—stomach cancer	0.000141	0.000338	CcSEcCtD
Foscarnet—Rash—Methotrexate—stomach cancer	0.00014	0.000335	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—stomach cancer	0.00014	0.000335	CcSEcCtD
Foscarnet—Headache—Methotrexate—stomach cancer	0.000139	0.000333	CcSEcCtD
Foscarnet—Asthenia—Doxorubicin—stomach cancer	0.000138	0.00033	CcSEcCtD
Foscarnet—Dizziness—Epirubicin—stomach cancer	0.000137	0.000329	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—stomach cancer	0.000136	0.000325	CcSEcCtD
Foscarnet—Vomiting—Epirubicin—stomach cancer	0.000132	0.000316	CcSEcCtD
Foscarnet—Nausea—Methotrexate—stomach cancer	0.000132	0.000315	CcSEcCtD
Foscarnet—Diarrhoea—Doxorubicin—stomach cancer	0.000131	0.000315	CcSEcCtD
Foscarnet—Rash—Epirubicin—stomach cancer	0.000131	0.000313	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ACAD8—stomach cancer	0.000131	0.00673	CbGpPWpGaD
Foscarnet—Dermatitis—Epirubicin—stomach cancer	0.000131	0.000313	CcSEcCtD
Foscarnet—Headache—Epirubicin—stomach cancer	0.00013	0.000311	CcSEcCtD
Foscarnet—Dizziness—Doxorubicin—stomach cancer	0.000127	0.000304	CcSEcCtD
Foscarnet—Nausea—Epirubicin—stomach cancer	0.000123	0.000295	CcSEcCtD
Foscarnet—Vomiting—Doxorubicin—stomach cancer	0.000122	0.000292	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000122	0.00626	CbGpPWpGaD
Foscarnet—Rash—Doxorubicin—stomach cancer	0.000121	0.00029	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—stomach cancer	0.000121	0.00029	CcSEcCtD
Foscarnet—Headache—Doxorubicin—stomach cancer	0.00012	0.000288	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GMPR2—stomach cancer	0.000117	0.006	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—FGG—stomach cancer	0.000114	0.00589	CbGpPWpGaD
Foscarnet—Nausea—Doxorubicin—stomach cancer	0.000114	0.000273	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—THBD—stomach cancer	0.000112	0.00578	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SUCLG1—stomach cancer	0.000107	0.00549	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—IDH3B—stomach cancer	0.000107	0.00549	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PPIA—stomach cancer	0.000104	0.00535	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SERPINA1—stomach cancer	0.0001	0.00515	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NDUFV1—stomach cancer	9.91e-05	0.0051	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NDUFS1—stomach cancer	9.91e-05	0.0051	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SPARC—stomach cancer	9.05e-05	0.00466	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—F2R—stomach cancer	9.05e-05	0.00466	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IRF1—stomach cancer	8.85e-05	0.00456	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PGLS—stomach cancer	8.83e-05	0.00455	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—BLVRB—stomach cancer	8.83e-05	0.00455	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPAP2A—stomach cancer	8.43e-05	0.00434	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—KRAS—stomach cancer	8.21e-05	0.00423	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC1A2—stomach cancer	7.89e-05	0.00406	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CD44—stomach cancer	7.69e-05	0.00396	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—stomach cancer	7.54e-05	0.00388	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NDUFA2—stomach cancer	7.51e-05	0.00387	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CKB—stomach cancer	7.51e-05	0.00387	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—FBP1—stomach cancer	7.51e-05	0.00387	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CA1—stomach cancer	7.51e-05	0.00387	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLIN2—stomach cancer	7.06e-05	0.00364	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—HRAS—stomach cancer	6.98e-05	0.00359	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CA2—stomach cancer	6.87e-05	0.00354	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NT5E—stomach cancer	6.7e-05	0.00345	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PGAM1—stomach cancer	6.7e-05	0.00345	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PPP2R1A—stomach cancer	6.54e-05	0.00337	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—ALB—stomach cancer	6.47e-05	0.00333	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALDH7A1—stomach cancer	6.39e-05	0.00329	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLCE1—stomach cancer	6.39e-05	0.00329	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—UMPS—stomach cancer	6.12e-05	0.00315	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—FYN—stomach cancer	5.77e-05	0.00297	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PDHA1—stomach cancer	5.69e-05	0.00293	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ECHS1—stomach cancer	5.69e-05	0.00293	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.48e-05	0.00282	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—FADS1—stomach cancer	5.35e-05	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TYMP—stomach cancer	5.35e-05	0.00276	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SREBF2—stomach cancer	5.01e-05	0.00258	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—RORA—stomach cancer	4.95e-05	0.00255	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PLAU—stomach cancer	4.92e-05	0.00253	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CAV1—stomach cancer	4.81e-05	0.00247	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—APOA1—stomach cancer	4.8e-05	0.00247	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALDOB—stomach cancer	4.64e-05	0.00239	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PRKCB—stomach cancer	4.57e-05	0.00236	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALOX5—stomach cancer	4.31e-05	0.00222	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—DPYD—stomach cancer	4.24e-05	0.00218	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—ALB—stomach cancer	4.2e-05	0.00216	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—APOA1—stomach cancer	4.15e-05	0.00214	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SERPINE1—stomach cancer	3.81e-05	0.00196	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALB—stomach cancer	3.8e-05	0.00196	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTT1—stomach cancer	3.75e-05	0.00193	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP2A6—stomach cancer	3.71e-05	0.00191	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RHOA—stomach cancer	3.67e-05	0.00189	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—NOS3—stomach cancer	3.63e-05	0.00187	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKR1C3—stomach cancer	3.61e-05	0.00186	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.56e-05	0.00183	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ENO1—stomach cancer	3.52e-05	0.00181	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ALB—stomach cancer	3.29e-05	0.00169	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CD44—stomach cancer	3.12e-05	0.00161	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	2.69e-05	0.00139	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPP2R1A—stomach cancer	2.65e-05	0.00137	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFA—stomach cancer	2.62e-05	0.00135	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTP1—stomach cancer	2.6e-05	0.00134	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HMOX1—stomach cancer	2.57e-05	0.00132	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK3—stomach cancer	2.48e-05	0.00128	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TYMS—stomach cancer	2.42e-05	0.00124	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM1—stomach cancer	2.39e-05	0.00123	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK1—stomach cancer	2.36e-05	0.00121	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ERCC2—stomach cancer	2.25e-05	0.00116	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KRAS—stomach cancer	2.23e-05	0.00115	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	2.13e-05	0.0011	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTHFR—stomach cancer	2.11e-05	0.00109	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CA—stomach cancer	2.05e-05	0.00105	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TP53—stomach cancer	1.98e-05	0.00102	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CAV1—stomach cancer	1.95e-05	0.001	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APOA1—stomach cancer	1.94e-05	0.001	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HRAS—stomach cancer	1.89e-05	0.000974	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PPARG—stomach cancer	1.71e-05	0.000882	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALB—stomach cancer	1.54e-05	0.000793	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NOS3—stomach cancer	1.47e-05	0.000759	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—stomach cancer	1.35e-05	0.000694	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CA—stomach cancer	8.29e-06	0.000427	CbGpPWpGaD
